RxDoctor Payments Data

Madison Edwards, PA

Physician Assistant · Florence, SCNPI 1144969098

Payments from drug & device makers

$4,105in general payments, 2019–2025

Across 215 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$710
  • AstraZeneca$535
  • Forte Bio-pharma LLC$177
  • UCB, Inc.$166
  • GSK$153
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$4,105100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,105 in reported general payments places this provider in the 85th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$405
Medicare patients
13
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab122$1,079,826
Enbrel SureclickEtanercept22$163,251
RinvoqUpadacitinib24$160,284
EnbrelEtanercept11$80,147
Xeljanz XrTofacitinib Citrate12$69,929
KevzaraSarilumab13$56,276
NeurontinGabapentin13$14,501
Diclofenac Sodium141$9,742
MethotrexateMethotrexate Sodium544$8,513
Hydroxychloroquine Sulfate286$8,449
Leflunomide203$6,431
Gabapentin251$3,752
Celecoxib51$2,315
Prednisone495$2,056
Azathioprine71$1,690

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$1,216$160,28424 claims
AmgenEnbrel$710$80,14711 claims
SanofiKevzara$126$56,27613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →